These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 22344624)
21. Calcium channel blocker azelnidipine reduces glucose intolerance in diabetic mice via different mechanism than angiotensin receptor blocker olmesartan. Iwai M; Li HS; Chen R; Shiuchi T; Wu L; Min LJ; Li JM; Tsuda M; Suzuki J; Tomono Y; Tomochika H; Mogi M; Horiuchi M J Pharmacol Exp Ther; 2006 Dec; 319(3):1081-7. PubMed ID: 16990512 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerability of candesartan cilexetil in special patient groups. Trenkwalder P Blood Press Suppl; 2000; 1():27-30. PubMed ID: 11059633 [TBL] [Abstract][Full Text] [Related]
24. Long-term treatment with an angiotensin II receptor blocker decreases adipocyte size and improves insulin signaling in obese Zucker rats. Muñoz MC; Giani JF; Dominici FP; Turyn D; Toblli JE J Hypertens; 2009 Dec; 27(12):2409-20. PubMed ID: 19901849 [TBL] [Abstract][Full Text] [Related]
25. Effects of combined candesartan and ACE inhibitors on BNP, markers of inflammation and oxidative stress, and glucose regulation in patients with symptomatic heart failure. White M; Lepage S; Lavoie J; De Denus S; Leblanc MH; Gossard D; Whittom L; Racine N; Ducharme A; Dabouz F; Rouleau JL; Touyz R J Card Fail; 2007 Mar; 13(2):86-94. PubMed ID: 17395047 [TBL] [Abstract][Full Text] [Related]
26. Effects of valsartan on diabetic cardiomyopathy in rats with type 2 diabetes mellitus. Yang ZH; Peng XD Chin Med J (Engl); 2010 Dec; 123(24):3640-3. PubMed ID: 22166644 [TBL] [Abstract][Full Text] [Related]
27. Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET. Philipp T; Martinez F; Geiger H; Moulin B; Mourad G; Schmieder R; Lièvre M; Heemann U; Legendre C Nephrol Dial Transplant; 2010 Mar; 25(3):967-76. PubMed ID: 19887503 [TBL] [Abstract][Full Text] [Related]
28. Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives. Iimura O; Shimamoto K; Matsuda K; Masuda A; Takizawa H; Higashiura K; Miyazaki Y; Hirata A; Ura N; Nakagawa M Am J Hypertens; 1995 Apr; 8(4 Pt 1):353-7. PubMed ID: 7619347 [TBL] [Abstract][Full Text] [Related]
29. Effects of the angiotensin receptor blocker candesartan on arterial stiffness and markers of extracellular matrix metabolism in patients with essential hypertension. Sasamura H; Kitamura Y; Nakamura M; Ryuzaki M; Saruta T Clin Exp Hypertens; 2006 Jul; 28(5):511-20. PubMed ID: 16820347 [TBL] [Abstract][Full Text] [Related]
30. A double-blind, randomized, placebo-controlled multicenter clinical trial to evaluate the effects of the angiotensin II receptor blocker candesartan cilexetil on intimal hyperplasia after coronary stent implantation. Radke PW; Figulla HR; Drexler H; Klues HG; Mügge A; Silber S; Daniel W; Schmeisser A; Reifart N; Motz W; Büttner HJ; Fischer D; Ortlepp JR; Schaefers K; Hoffmann R; Hanrath P; Am Heart J; 2006 Oct; 152(4):761.e1-6. PubMed ID: 16996855 [TBL] [Abstract][Full Text] [Related]
31. Beneficial action of candesartan cilexetil plus amlodipine or ACE inhibitors in chronic nondiabetic renal disease. Homma K; Hayashi K; Kanda T; Yoshioka K; Takamatsu I; Tatematsu S; Kumagai H; Wakino S; Saruta T J Hum Hypertens; 2004 Dec; 18(12):879-84. PubMed ID: 15295613 [TBL] [Abstract][Full Text] [Related]
32. Activation of I2-imidazoline receptors by agmatine improved insulin sensitivity through two mechanisms in type-2 diabetic rats. Su CH; Liu IM; Chung HH; Cheng JT Neurosci Lett; 2009 Jul; 457(3):125-8. PubMed ID: 19429177 [TBL] [Abstract][Full Text] [Related]
33. [Change from ACE inhibitor, Ca-antagonist or beta-blocker to candesartan cilexetil: better efficacy and tolerance. SWITCH study (German study segment)]. Baumgart P; Reismann J; Pohlmeyer H; Düsing R Dtsch Med Wochenschr; 2001 May; 126(19):547-50. PubMed ID: 11402910 [TBL] [Abstract][Full Text] [Related]
34. Voluntary running improves in vivo insulin resistance in high-salt diet fed rats. Qin B; Oshida Y; Li P; Kubota M; Nagasaki M; Sato Y Exp Biol Med (Maywood); 2007 Nov; 232(10):1330-7. PubMed ID: 17959846 [TBL] [Abstract][Full Text] [Related]
35. Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes. Bitar MS; Al-Saleh E; Al-Mulla F Life Sci; 2005 Sep; 77(20):2552-73. PubMed ID: 15936776 [TBL] [Abstract][Full Text] [Related]
36. Blockade of the Renin-Angiotensin system improves insulin receptor signaling and insulin-stimulated skeletal muscle glucose transport in burn injury. Kasper SO; Phillips EE; Castle SM; Daley BJ; Enderson BL; Karlstad MD Shock; 2011 Jan; 35(1):80-5. PubMed ID: 20823693 [TBL] [Abstract][Full Text] [Related]
37. Statin modulates insulin signaling and insulin resistance in liver and muscle of rats fed a high-fat diet. Lalli CA; Pauli JR; Prada PO; Cintra DE; Ropelle ER; Velloso LA; Saad MJ Metabolism; 2008 Jan; 57(1):57-65. PubMed ID: 18078859 [TBL] [Abstract][Full Text] [Related]
38. Preserving target-organ function with candesartan cilexetil in patients with hypertension. Zannad F Blood Press Suppl; 2000; 1():36-9. PubMed ID: 11059635 [TBL] [Abstract][Full Text] [Related]
39. High-fat diet impairs the effects of a single bout of endurance exercise on glucose transport and insulin sensitivity in rat skeletal muscle. Tanaka S; Hayashi T; Toyoda T; Hamada T; Shimizu Y; Hirata M; Ebihara K; Masuzaki H; Hosoda K; Fushiki T; Nakao K Metabolism; 2007 Dec; 56(12):1719-28. PubMed ID: 17998027 [TBL] [Abstract][Full Text] [Related]
40. The angiotensin II receptor antagonist candesartan cilexetil (TCV-116) ameliorates retinal disorders in rats. Nagisa Y; Shintani A; Nakagawa S Diabetologia; 2001 Jul; 44(7):883-8. PubMed ID: 11508274 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]